ALOX5AP Antibody

• Catalog number
  DF8367
• Price
  Please ask
• Size
  100µL

• Type
  primary antibody
• Shipping
  Ice bag
• Antigen
  ALOX5AP
• Reactivity
  Human
• Clonality
  Polyclonal
• Application
  WB,ELISA
• Application_advice
  WB 1:1000-3000
• Immunogen
  A synthesized peptide derived from human ALOX5AP.
• Purification
  The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
• Format
  Liquid
• Concentration
  1mg/ml
• Fragment
  Fab fragment
• Storage_Buffer
  Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.
• Specificity
  ALOX5AP Antibody detects endogenous levels of total ALOX5AP.
• GendID
  241
• Gene
  ALOX5AP
• GeneAlias
  ALOX5AP FLAP
• Unigene
  Hs.507658;
• Swiss Prot
  P20292
• Weight
  18 kDa
• Datasheet
• Msds
• Properties
  If you buy Antibodies supplied by Affinity Biosciences they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.
• French translation
  anticorps

• Gene target
  ALOX5AP  
• Gene symbol
  ALOX5AP
• Short name
  ALOX5AP Antibody
• Technique
  Antibody, antibodies against human proteins, antibodies for
• Host
  Rabbit
• Isotype
  IgG
• Alternative name
  ALOX5AP (antibody to-)
• Alternative technique
  antibodies

Gene info

• Identity
  HGNC:436
• Gene
  ALOX5AP
• Long gene name
  arachidonate 5-lipoxygenase activating protein
• Synonyms gene name
  • arachidonate 5-lipoxygenase-activating protein
• Synonyms
  • FLAP
• Synonyms name
  • five-lipoxygenase activating protein
  • MK-886-binding protein
• GenBank acession
  • AH001462
• Locus
  13q12.3
• Discovery year
  1997-10-10
• Entrez gene record
  241
• Pubmed identfication
  • 1673682
  • 10036194
• RefSeq identity
  • NM_001629
• VEGA ID
  OTTHUMG00000016677
• Locus Specific Databases
  • The Globin Gene Server

MeSH Data

• Name
  Cloning, Molecular
• Concept
  Scope note: The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
• Tree numbers
  • E05.393.220
• Qualifiers
  drug effects, methods, radiation effects

Similar products